Omega Therapeutics, Inc. (OMGA)
NASDAQ: OMGA · Real-Time Price · USD
1.040
-0.070 (-6.31%)
At close: Nov 4, 2024, 4:00 PM
1.100
+0.060 (5.77%)
After-hours: Nov 4, 2024, 4:28 PM EST

Omega Therapeutics Revenue

Omega Therapeutics had revenue of $2.13M in the quarter ending June 30, 2024, with 181.16% growth. This brings the company's revenue in the last twelve months to $6.31M, up 142.47% year-over-year. In the year 2023, Omega Therapeutics had annual revenue of $3.09M with 49.25% growth.

Revenue (ttm)
$6.31M
Revenue Growth
+142.47%
P/S Ratio
9.09
Revenue / Employee
$67,170
Employees
94
Market Cap
57.36M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20233.09M1.02M49.25%
Dec 31, 20222.07M1.93M1,339.58%
Dec 31, 2021144.00K--
Dec 31, 2020---
Dec 31, 2019---
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
111, Inc. 2.03B
LENSAR 45.12M
Milestone Scientific 8.42M
Kronos Bio 8.41M
Shattuck Labs 4.12M
Serina Therapeutics 3.17M
Syros Pharmaceuticals 386.00K
Revenue Rankings